2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
2.15 Financial assets (continued)
(b) Available-for-sale financial assets (continued)
Investments in equity instruments whose fair value cannot be reliably measured are measured at cost less
impairment loss.
Available-for-sale financial assets are classified as non-current assets unless they are expected to be realised
within 12 months after the reporting date.
A financial asset is derecognised where the contractual right to receive cash flows from the asset has expired. On
derecognition of a financial asset in its entirety, the difference between the carrying amount and the sum of the
consideration received and any cumulative gain or loss that had been recognised in other comprehensive income is
recognised in profit or loss.
Regular way purchases or sales are purchases or sales of financial assets that require delivery of assets within the
period generally established by regulation or convention in the marketplace concerned. All regular way purchases and
sales of financial assets are recognised or derecognised on the trade date that is, the date that the Group and the
Company commit to purchase or sell the asset.
2.16 Impairment of financial assets
The Group and the Company assess at each reporting date whether there is any objective evidence that a financial asset
is impaired.
(a) Trade and other receivables and other financial assets carried at amortised cost
To determine whether there is objective evidence that an impairment loss on financial assets has been incurred,
the Group and the Company consider factors such as the probability of insolvency or significant financial difficulties
of the debtor and default or significant delay in payments. For certain categories of financial assets, such as trade
receivables, receivables that are assessed not to be impaired individually are subsequently assessed for impairment
on a collective basis based on similar risk characteristics. Objective evidence of impairment for a portfolio of
receivables could include the Group’s and the Company’s past experience of collecting payments, an increase in
the number of delayed payments in the portfolio past the average credit period and observable changes in national
or local economic conditions that correlate with default on receivables.
If any such evidence exists, the amount of impairment loss is measured as the difference between the asset’s
carrying amount and the present value of estimated future cash flows discounted at the financial asset’s original
effective interest rate. The impairment loss is recognised in profit or loss.
The carrying amount of the financial asset is reduced by the impairment loss directly for all financial assets with
the exception of receivables, where the carrying amount is reduced through the use of an allowance account. When
a receivable becomes uncollectible, it is written off against the allowance account.
If in a subsequent period, the amount of the impairment loss decreases and the decrease can be related objectively
to an event occurring after the impairment was recognised, the previously recognised impairment loss is reversed
to the extent that the carrying amount of the asset does not exceed its amortised cost at the reversal date. The
amount of reversal is recognised in profit or loss.
223
Notes to the
Financial Statements
For the financial year ended 31 December 2014 (continued)
KPJ Healthcare Berhad annual report
2014
